X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
20
PharmaCompass offers a list of Digoxin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Digoxin manufacturer or Digoxin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Digoxin manufacturer or Digoxin supplier.
PharmaCompass also assists you with knowing the Digoxin API Price utilized in the formulation of products. Digoxin API Price is not always fixed or binding as the Digoxin Price is obtained through a variety of data sources. The Digoxin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Metildigoxin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Metildigoxin, including repackagers and relabelers. The FDA regulates Metildigoxin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Metildigoxin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Metildigoxin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Metildigoxin supplier is an individual or a company that provides Metildigoxin active pharmaceutical ingredient (API) or Metildigoxin finished formulations upon request. The Metildigoxin suppliers may include Metildigoxin API manufacturers, exporters, distributors and traders.
click here to find a list of Metildigoxin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Metildigoxin DMF (Drug Master File) is a document detailing the whole manufacturing process of Metildigoxin active pharmaceutical ingredient (API) in detail. Different forms of Metildigoxin DMFs exist exist since differing nations have different regulations, such as Metildigoxin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Metildigoxin DMF submitted to regulatory agencies in the US is known as a USDMF. Metildigoxin USDMF includes data on Metildigoxin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Metildigoxin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Metildigoxin suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Metildigoxin Drug Master File in Japan (Metildigoxin JDMF) empowers Metildigoxin API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Metildigoxin JDMF during the approval evaluation for pharmaceutical products. At the time of Metildigoxin JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Metildigoxin suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Metildigoxin Drug Master File in Korea (Metildigoxin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Metildigoxin. The MFDS reviews the Metildigoxin KDMF as part of the drug registration process and uses the information provided in the Metildigoxin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Metildigoxin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Metildigoxin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Metildigoxin suppliers with KDMF on PharmaCompass.
A Metildigoxin CEP of the European Pharmacopoeia monograph is often referred to as a Metildigoxin Certificate of Suitability (COS). The purpose of a Metildigoxin CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Metildigoxin EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Metildigoxin to their clients by showing that a Metildigoxin CEP has been issued for it. The manufacturer submits a Metildigoxin CEP (COS) as part of the market authorization procedure, and it takes on the role of a Metildigoxin CEP holder for the record. Additionally, the data presented in the Metildigoxin CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Metildigoxin DMF.
A Metildigoxin CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Metildigoxin CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Metildigoxin suppliers with CEP (COS) on PharmaCompass.
A Metildigoxin written confirmation (Metildigoxin WC) is an official document issued by a regulatory agency to a Metildigoxin manufacturer, verifying that the manufacturing facility of a Metildigoxin active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Metildigoxin APIs or Metildigoxin finished pharmaceutical products to another nation, regulatory agencies frequently require a Metildigoxin WC (written confirmation) as part of the regulatory process.
click here to find a list of Metildigoxin suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Metildigoxin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Metildigoxin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Metildigoxin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Metildigoxin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Metildigoxin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Metildigoxin suppliers with NDC on PharmaCompass.
Metildigoxin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Metildigoxin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Metildigoxin GMP manufacturer or Metildigoxin GMP API supplier for your needs.
A Metildigoxin CoA (Certificate of Analysis) is a formal document that attests to Metildigoxin's compliance with Metildigoxin specifications and serves as a tool for batch-level quality control.
Metildigoxin CoA mostly includes findings from lab analyses of a specific batch. For each Metildigoxin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Metildigoxin may be tested according to a variety of international standards, such as European Pharmacopoeia (Metildigoxin EP), Metildigoxin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Metildigoxin USP).
Market Place
